Cibus Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cibus Inc.
- Former names
- Calyxt, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2870 — Agricultural Chemicals
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CBUS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001705843
- EIN
- 27-1967997
Board of directors
-
Anna Ewa Kozicz-Stankiewicz · DirectorSince 2023
-
August J. Moretti · DirectorSince 2024
-
Christopher J. Neugent · DirectorSince 2023
-
Craig Wichner · DirectorSince 2025
-
Fassberg Jonathan · DirectorSince 2023
-
Gerhard Prante · DirectorSince 2023
-
James C. Collins Jr. · DirectorSince 2023
-
Jean-Pierre Jules Lehmann · DirectorSince 2023
-
Keith Allen Walker · DirectorSince 2023
-
Kimberly Ann Box · DirectorSince 2025
-
Kimberly K. Nelson · DirectorSince 2023
-
Mark Terrence Finn · DirectorSince 2023
-
Michael A. Carr · Director · President and CEOSince 2023
-
Peter Beetham · Director · Interim CEO, Pres & COOSince 2023
-
Philippe Dumont · DirectorSince 2023
-
Rory B. Riggs · Director · Chief Executive OfficerSince 2023
-
Thomas Urban · DirectorSince 2026
-
Yves J. Ribeill · DirectorSince 2023
Chief executives
Rory B. Riggs
· Chief Executive Officer
Dates unknown
Michael A. Carr
· President and CEO
Dates unknown
Dates unknown
Director election results
Annual meeting of June 2, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.4%
-
99.4%
-
99.6%
-
99.7%
-
100.0%
Board connections
5 of this board's directors also sit on 6 other boards.
- via James C. Collins Jr.
- via James C. Collins Jr.
- via Kimberly Ann Box
- via Rory B. Riggs
- via Kimberly K. Nelson
- via August J. Moretti
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 8, 2026 | Craig Wichner Officer (CEO) | Grant or award | +894,309 | — | — |
| Jun 2, 2026 | Gerhard Prante Director | Grant or award | +64,748 | — | — |
| Jun 2, 2026 | Jean-Pierre Jules Lehmann Director | Grant or award | +64,748 | — | — |
| Jun 2, 2026 | Thomas Urban Director | Grant or award | +64,748 | — | — |
| Apr 24, 2026 | Sauer Noel Officer (Sr VP, Research) | Grant or award | +38,000 | — | — |
| Apr 24, 2026 | Stokes Jason Officer (CAO, Gen Csl & Corp Secy) | Grant or award | +57,000 | — | — |
| Apr 24, 2026 | Broos Carlo Officer (CFO) | Grant or award | +57,000 | — | — |
| Apr 24, 2026 | Gocal Gregory Francis William Officer (Chief Scientific Officer & EVP) | Grant or award | +57,000 | — | — |
| Apr 24, 2026 | Peter Beetham Officer (Interim CEO, Pres & COO) | Grant or award | +195,000 | — | — |
| Mar 30, 2026 | Sauer Noel Officer (Sr VP, Research) | Shares withheld for tax | −1,763 | $1.84 | $3,244 |
| Mar 30, 2026 | Stokes Jason Officer (CLO, Gen Csl & Secy) | Shares withheld for tax | −3,695 | $1.83 | $6,762 |
| Mar 30, 2026 | Broos Carlo Officer (CFO) | Shares withheld for tax | −3,676 | $1.87 | $6,874 |
| Mar 30, 2026 | Gocal Gregory Francis William Officer (Chief Scientific Officer & EVP) | Shares withheld for tax | −8,954 | $1.82 | $16,296 |
| Mar 30, 2026 | Peter Beetham Director, Officer (Interim CEO, Pres & COO) | Shares withheld for tax | −16,112 | $1.85 | $29,807 |
| Feb 19, 2026 | Stokes Jason Officer (CLO, Gen Csl & Secy) | Shares withheld for tax | −4,795 | $2.98 | $14,289 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.